RecruitingChronic Myeloid LeukemiaChronic Phase Chronic Myelogenous Leukemia
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Sponsor: University of California, Irvine
You may qualify if…
- ✓ 18 years of age or older
- ✓ Diagnosed with chronic myeloid leukemia (CML) and in the chronic phase (CML-CP)
- ✓ Currently being treated with one of four cancer medications - imatinib, dasatinib, bosutinib, or nilotinib
- ✓ A patient at the UCI Chao Family Comprehensive Cancer Center (CFCCC), or
- ✓ A member of a patient support group organized by the CML Buster Foundation
- ✓ Do not meet any of the criteria listed under "Exclusion Requirements"
You may not qualify if…
- ✕ Unable to read and speak English
- ✕ Impaired decisional capacity to consent
Where it's recruiting
California
Orange
Source: ClinicalTrials.gov · NCT06229860 · last updated 2026-03-10